Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Pilot Study Assessing the Impact on the Quality of Hospital Care After the Introduction of Rotavirus Vaccination in Belgium

NCT01592838 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01592838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01592838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Pilot Study Assessing the Impact on the Quality of Hospital Care After the Introduction of Rotavirus Vaccination in Belgium
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
December 31, 2013
Completion date
October 31, 2014
Enrollment
1 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

infections, rotavirus